Alcon Inc income statement
In fiscal 2025, Alcon Inc reported revenue of $10.40bn, up 4.9% on the year before, operating income of $1.36bn (a 13.1% margin) and net income of $980m, or $1.98 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.8 | 7.2 | 7.5 | 6.8 | 8.3 | 8.7 | 9.5 | 9.9 | 10.4 |
| Cost of revenue | 3.6 | 4.0 | 3.7 | 3.8 | 3.6 | 3.9 | 4.1 | 4.3 | 4.6 |
| Gross profit | 3.2 | 3.2 | 3.7 | 2.9 | 4.7 | 4.7 | 5.2 | 5.5 | 5.7 |
| Research and development | 0.6 | 0.6 | 0.7 | 0.7 | 0.8 | 0.7 | 0.8 | 0.9 | 1.0 |
| Operating income | −0.1 | −0.2 | −0.2 | −0.5 | 0.6 | 0.7 | 1.0 | 1.4 | 1.4 |
| Interest expense | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 |
| Income before tax | −0.1 | −0.3 | −0.3 | −0.6 | 0.4 | 0.5 | 0.8 | 1.3 | 1.2 |
| Income tax | −0.4 | −0.1 | 0.3 | −0.1 | 0.0 | 0.1 | −0.1 | 0.2 | 0.2 |
| Net income | 0.3 | −0.2 | −0.7 | −0.5 | 0.4 | 0.3 | 1.0 | 1.0 | 1.0 |
| Diluted EPS | $0.52 | −$0.46 | −$1.34 | −$1.09 | $0.76 | $0.68 | $1.96 | $2.05 | $1.98 |
| Diluted shares (average) | 488m | 488m | 488m | 489m | 493m | 494m | 497m | 498m | 496m |
Compare with peers
- Intuitive Surgical income statement
- Baxter International income statement
- Zimmer Biomet income statement
- Edwards Lifesciences income statement
- Steris income statement
Head to head: ALC vs ISRGALC vs BAXALC vs ZBH
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies